Results 131 to 140 of about 8,884 (175)
Microbial biotransformation of Syzygium australe modifies metabolomic profile assessed with multivariate analysis and molecular networking: In vitro and computational studies. [PDF]
Sci RepElzayat HH +5 more
europepmc +1 more source
Orlistat Confers Neuroprotection in Traumatic Brain Injury by Modulating Microglial Lipid Metabolism. [PDF]
CellsYu C +11 more
europepmc +1 more source
Economic Evaluation of Medications in Prevention and Treatment of Obesity: A Systematic Review. [PDF]
Int J Prev MedAfshari S +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 1998
Orlistat (tetrahydrolipstatin) is an inhibitor of pancreatic and other lipases. As a pancreatic lipase inhibitor, it acts in the gastrointestinal lumen and is indicated for use in obesity. Serum total cholesterol and low density lipoprotein-cholesterol levels were reduced in obese, but otherwise healthy, patients during < or = 2 years' orlistat ...
W, McNeely, P, Benfield
openaire +3 more sources
Orlistat (tetrahydrolipstatin) is an inhibitor of pancreatic and other lipases. As a pancreatic lipase inhibitor, it acts in the gastrointestinal lumen and is indicated for use in obesity. Serum total cholesterol and low density lipoprotein-cholesterol levels were reduced in obese, but otherwise healthy, patients during < or = 2 years' orlistat ...
W, McNeely, P, Benfield
openaire +3 more sources
Intensive and Critical Care Nursing, 1999
The introduction of orlistat (Roche, UK) at the end of last year received considerable media coverage and was heralded in some quarters as the 'quick fix' for those wishing to lose weight without the pain of dieting. This description is far from accurate but treatment with orlistat may have a role in patients for whom obesity is a serious and even life-
Crenier, Laurent, Sternon, J.
openaire +5 more sources
The introduction of orlistat (Roche, UK) at the end of last year received considerable media coverage and was heralded in some quarters as the 'quick fix' for those wishing to lose weight without the pain of dieting. This description is far from accurate but treatment with orlistat may have a role in patients for whom obesity is a serious and even life-
Crenier, Laurent, Sternon, J.
openaire +5 more sources
Reactions Weekly, 2009
ZusammenfassungOrlistat (Tetrahydrolipstatin) ist der erste im Darm (peripher) nachgewiesen wirksame, pharmakologisch effektive Fettresorptionshemmer. Orlistat hemmt die intestinale Triglyzeridlipase und senkt so die gastrointestinale Fettspaltung dosisabhängig um bis zu etwa 35 Prozent.
+4 more sources
ZusammenfassungOrlistat (Tetrahydrolipstatin) ist der erste im Darm (peripher) nachgewiesen wirksame, pharmakologisch effektive Fettresorptionshemmer. Orlistat hemmt die intestinale Triglyzeridlipase und senkt so die gastrointestinale Fettspaltung dosisabhängig um bis zu etwa 35 Prozent.
+4 more sources
Hospital Pharmacy, 1999
Each month, subscribers to The Formulary® Monograph Service receive five to six researched monographs on drugs that are newly released or are in late Phase III trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada +2 more
openaire +1 more source
Each month, subscribers to The Formulary® Monograph Service receive five to six researched monographs on drugs that are newly released or are in late Phase III trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada +2 more
openaire +1 more source